The Selebrek® CTO balloon dilation catheter has been approved by the Food and Drug Administration (FDA) for aiming to market. this can be the third coronary interventional balloon dilation catheter approved by FDA once the PTCA balloon dilation catheter and NC PTCA balloon dilation catheter. Broaden the market of Kossel coronary intervention field, and bring another sharp tool for clinical! In the Gregorian calendar month of this year, the CTO balloon dilation catheter has already received authority approval. The diameter of the tip entrance will reach zero.016”, Minimum balloon profile will reach zero.024”. Meanwhile, the spiral cutting style of the hypocatheter effectively enhances the pushing ability of the catheter. creating it straightforward to withstand vessel pathology, particularly occlusion.

Here is that the content:

• l Balloon anchoring

• l Side branch technology

• l Preexpansion of collateral vessels

Balloon anchoring

Balloon anchoring is one in all the most reasons why the guide catheter is displaced or the supporting force is deficient, and therefore the guide wire or balloon cannot withstand the CTO occlusion section. Balloon anchoring technology will improve the supporting force of guiding catheter and avoid catheter displacement or prolapse. Balloon anchoring technology is divided into 2 types: lateral anchoring and main anchoring.

1. Collateral anchoring refers to increasing the balloon within the branch vessel close to the target lesion, thus on fix the guiding catheter and enhance its coaxiality and supporting force, thus on facilitate the guide wire, balloon or tubing to withstand the lesion.

2. Main branch anchoring refers to increasing OTW balloon within the central cavity of the most branch close to the lesion, thus on fix the guiding catheter, enhance its coaxiality and supporting force, and supply stronger supporting force for the guide wire. If the CTO lesion is long, OTW balloon with matching lumen diameter is wont to expand within the proximal section of CTO lesion, however it should be confirmed that the balloon is within the true lumen before enlargement.

Side branch technology

When there's a collateral branch within the occluded section, the guide wire cannot withstand the occluded section however invariably enters the collateral branch. employing a tiny balloon at the gap of the collateral branch for low and gentle enlargement will facilitate the guide wire withstand the lesion.

When the enlargement pressure is high, it's going to cause the formation of false lumen, layer or perforation round the occluded section of the vessel, that makes it tougher for the guide wire to enter the distal section of CTO. Therefore, it ought to be rigorously hand-picked.

Pre expansion of collateral vessels

Some patients' collateral circulation vessels ar tiny or terribly tortuous. At this point, it's necessary to use a balloon with tiny outer diameter and low to isolate collateral circulation vessels.

KOSSEL, established in 2013, could be a wonderful enterprise to develop, manufacture, and market a spread of interventional medical devices. Current product portfolio includes PTCA balloon catheters (contain each semi-compliant and non-compliant balloons), CTO balloon dilation catheter, PTA balloon dilatation catheter, and so on. KOSSEL has established a strict quality assurance system and is ISO 13485 certified. the corporate has obtained the producing allow for sophistication III together with implantable medical devices from the Chinese administrative body SFDA and is additionally formally registered with the North American country authority because the businessperson and medical device manufacturer for the North American country market. Being the medical device company in China specialized in interventional medical devices, KOSSEL stands prime within the business through its superior producing facility, experience in catheter production and a young and vigorous team of pros. we have a tendency to invariably welcome your consultation and visit, and that we won't allow you to down.